z-logo
open-access-imgOpen Access
Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy
Author(s) -
Carlo Lucioni,
Sergio Iannazzo,
S. Mazzi,
Giorgia Saporiti,
Silvia Chiroli
Publication year - 2015
Publication title -
global and regional health technology assessment
Language(s) - English
Resource type - Journals
eISSN - 2283-5733
pISSN - 2284-2403
DOI - 10.5301/grhta.5000189
Subject(s) - ponatinib , dasatinib , medicine , bosutinib , myeloid leukemia , nilotinib , oncology , imatinib

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom